BACKGROUND: The relationship between the shuttle walk test and peak oxygen consumption in patients with lung cancer has not previously been reported. A study was undertaken to examine this relationship in patients referred for lung cancer surgery to test the hypothesis that the shuttle walk test would be useful in this clinical setting. METHODS: 125 consecutive patients with potentially operable lung cancer were prospectively recruited. Each performed same day shuttle walking and treadmill walking tests. RESULTS: Shuttle walk distances ranged from 104 m to 1020 m and peak oxygen consumption ranged from 9 to 35 ml/kg/min. The shuttle walk distance significantly correlated with peak oxygen consumption (r = 0.67, p<0.001). All 55 patients who ...
BACKGROUND: The 6-minute walk test (6 MWT) is used to measure exercise capacity and assess prognosis...
Background and aim of the work: In patients with interstitial lung disease (ILD), the six-minute wal...
Exercise improves cardiovascular function in cancer survivors (CS) suffering from treatment-related ...
for evaluating the impact of shortness of breath on functional capacity in patients with advanced ca...
AbstractThe shuttle walk test (SWT) is a validated, incremental walking test for chronic obstructive...
BACKGROUND: There is emerging evidence regarding the efficacy of exercise training to improve exerci...
This study is aimed to (i) compare both the magnitude of impairment in exercise capacity and exercis...
Background:Breathlessness is common in patients with thoracic cancer but difficult to manage. The In...
The purpose of this study was to develop an incremental field exercise test of disability to use in ...
SummaryBackgroundThere has been no direct comparison between an incremental and endurance walking te...
Objective: To determine if the metabolic cost of the incremental shuttle-walking test protocol is th...
Background The incremental shuttle walk test (ISWT) is a standardised assessment for cardiac rehabil...
Objective: To determine the probability of oxygen desaturation in healthy individuals undergoing the...
International audienceBACKGROUND: Although the 6-min walk test (6MWT) is the gold standard for asses...
Background: There is increasing interest in screening for and diagnosing pulmonary hypertension earl...
BACKGROUND: The 6-minute walk test (6 MWT) is used to measure exercise capacity and assess prognosis...
Background and aim of the work: In patients with interstitial lung disease (ILD), the six-minute wal...
Exercise improves cardiovascular function in cancer survivors (CS) suffering from treatment-related ...
for evaluating the impact of shortness of breath on functional capacity in patients with advanced ca...
AbstractThe shuttle walk test (SWT) is a validated, incremental walking test for chronic obstructive...
BACKGROUND: There is emerging evidence regarding the efficacy of exercise training to improve exerci...
This study is aimed to (i) compare both the magnitude of impairment in exercise capacity and exercis...
Background:Breathlessness is common in patients with thoracic cancer but difficult to manage. The In...
The purpose of this study was to develop an incremental field exercise test of disability to use in ...
SummaryBackgroundThere has been no direct comparison between an incremental and endurance walking te...
Objective: To determine if the metabolic cost of the incremental shuttle-walking test protocol is th...
Background The incremental shuttle walk test (ISWT) is a standardised assessment for cardiac rehabil...
Objective: To determine the probability of oxygen desaturation in healthy individuals undergoing the...
International audienceBACKGROUND: Although the 6-min walk test (6MWT) is the gold standard for asses...
Background: There is increasing interest in screening for and diagnosing pulmonary hypertension earl...
BACKGROUND: The 6-minute walk test (6 MWT) is used to measure exercise capacity and assess prognosis...
Background and aim of the work: In patients with interstitial lung disease (ILD), the six-minute wal...
Exercise improves cardiovascular function in cancer survivors (CS) suffering from treatment-related ...